OpenAI’s independent path toward a 2027 IPO, reinforced by its 2025 for-profit restructuring and Microsoft’s 27% stake without full control, drives the 97.4% market-implied odds against an acquisition before year-end 2026. The company continues raising capital at valuations exceeding $1 trillion, expanding Codex capabilities through targeted acquisitions like Ona and Astral, and prioritizing AI safety over rushed public-market entry, as CEO Sam Altman recently confirmed. With only months remaining, the short timeline, established governance, and strong revenue momentum leave little room for a near-term sale. While a sudden regulatory shift or unforeseen board reversal could theoretically intervene, trader consensus views these outcomes as remote given the company’s demonstrated autonomy and capital access.